USANA Health Sciences (NYSE:USNA) Shares Up 4.8% - Still a Buy?

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report)'s stock price traded up 4.8% during trading on Thursday . The company traded as high as $32.00 and last traded at $32.34. 108,272 shares were traded during trading, a decline of 37% from the average session volume of 172,087 shares. The stock had previously closed at $30.87.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Sidoti lowered shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 18th. StockNews.com downgraded shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Finally, DA Davidson reduced their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating on the stock in a research note on Thursday, February 27th.

USANA Health Sciences Stock Up 1.4 %

The stock has a market capitalization of $627.70 million, a price-to-earnings ratio of 11.64, a P/E/G ratio of 0.93 and a beta of 0.98. The business's 50 day simple moving average is $32.96 and its 200-day simple moving average is $36.20.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The firm had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. On average, analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Remove Ads

Insider Activity

In other news, CEO Jim Brown sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $29.47, for a total value of $147,350.00. Following the sale, the chief executive officer now directly owns 15,716 shares in the company, valued at approximately $463,150.52. This trade represents a 24.14 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On USANA Health Sciences

Several hedge funds have recently added to or reduced their stakes in the business. Pzena Investment Management LLC boosted its position in USANA Health Sciences by 3.6% during the 4th quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company's stock worth $39,015,000 after buying an additional 37,466 shares during the period. Dimensional Fund Advisors LP raised its holdings in USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock worth $27,751,000 after purchasing an additional 55,059 shares during the last quarter. Pacer Advisors Inc. raised its holdings in USANA Health Sciences by 8.8% during the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company's stock worth $21,247,000 after purchasing an additional 47,745 shares during the last quarter. State Street Corp raised its holdings in USANA Health Sciences by 0.6% during the 3rd quarter. State Street Corp now owns 435,164 shares of the company's stock worth $16,501,000 after purchasing an additional 2,782 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in USANA Health Sciences by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company's stock worth $10,839,000 after purchasing an additional 4,829 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.